Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Biological & Pharmaceutical Bulletin|January 12, 2026
Exploratory Analysis for Development Predictive Models of Immune Checkpoint Inhibitor-Induced Myocarditis Using a Nationwide Claims DatabaseReina Yamamoto, Hirofumi Hamano, Koki Nakagomi, et al.
Pharmacoepidemiology and Drug Safety|September 18, 2018
Development and pharmacist-mediated use of tools for monitoring atypical antipsychotic-induced side effects related to blood glucose levelsShunsuke Ishida, Kenshi Takechi, Hiroshi Bando, et al.
Acta Medica Okayama|August 27, 2020
Successful Vancomycin Dose Adjustment in a Sepsis patient with Bacterial Meningitis Using Cystatin CMasayuki Chuma, Masateru Kondo, Yoshito Zamami, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 28, 2026
Machine learning approaches to predict early cardiac immune-related adverse events in patients receiving immune checkpoint inhibitorsMichael Sayer, Peter D Chang, Hirofumi Hamano, et al.
BMJ Open|December 14, 2019
Fall-related mortality trends in older Japanese adults aged ≥65 years: a nationwide observational studyHideharu Hagiya, Toshihiro Koyama, Yoshito Zamami, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2025
Unravelling the cardioprotective effects of calcitriol in Sunitinib-induced toxicity: A comprehensive in silico and in vitro studyYoshika Sakamoto, Takahiro Niimura, Mitsuhiro Goda, et al.
Family Practice|July 23, 2019
Oral anticoagulants usage in Japanese patients aged 18-74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims dataAyako Ohshima, Toshihiro Koyama, Aiko Ogawa, et al.
Leukemia Research|April 19, 2026
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBaseJun Matsumoto, Tatsuaki Takeda, Shiho Sugimoto, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combinationTakahiro Niimura, Mitsuhiro Goda, Koji Miyata, et al.
Cardio-Oncology (London, England)|March 5, 2025
Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapyAya F Ozaki, Michael Sayer, Hirofumi Hamano, et al.
Pageof 19